http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1625879-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f0b9736a98cf3fd9b58584e2bc96f03
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-74
filingDate 1989-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1991-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c92cedc44af11103a296ee1a36f52ba5
publicationDate 1991-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SU-1625879-A1
titleOfInvention Method of producing arylarsonic acid bromoanhydrides
abstract The invention relates to organic compounds of the mouse, in particular, the preparation of aryl arsonous acid bromides with a common C6H4X-As (OR) Br, where XH, n-CH3, o-OCH3, n-Br; R-C2H6-, H30-CjH7,, tert-C4 C, which can be used in the synthesis of active substances. The goal is to create a new way of obtaining new intermediates for the specified purpose. Synthesis is prepared by reaction of the corresponding ethyl-1 arylchloroarsine in the form of C H + X-As (C2Hj.) Cl with the corresponding alcohol in the presence of triethylamine by separating the resulting triethylamine hydrochloride followed by treatment with bromine. The process is carried out in oenzol or in CC14 at 20 ° C. Yield, Lt Kip., &Amp;C;(mmHg.); gross-la: a) 95; 117-118 (1); C10H14AsBrO; b) 93; 111-113 (1); C, H, Z AsBrO; c) 96; 100-102 (1); C8H 0AsBrO; d) 94; 139-141 (1); C H AsBrO; e) 92; 165-166 (3); C | 0H, 3A5BgO; e) 96; 145.5-146 (1); C ,, h (o- AsBrOj ,,. C 8 (L
priorityDate 1989-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID120337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415820794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53211344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423364395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471

Total number of triples: 34.